Pfizer announced that the Covid-19 vaccine for children under 5 will be available by the end of next month.

According to the report, the US Food and Drug Administration (FDA) will be making an emergency authorization request as soon as possible to start the process immediately as the vaccine is ready to be administered.

A close source stated that if the vaccine is proved to be successful, it will pave the way for a two-dose vaccine availability for children aged 6 months to 5 years.

Pfizer had previously admitted that the two-shot vaccine dose proved to be less preventive from Covid-19 in children aged 2 to 5 compared to older kids.

The FDA has pushed the pharmaceutical conglomerate teaming up with BioNTech to submit the application for the two-dose data.

“The idea is, let’s go ahead and start the review of two doses,” revealed an insider. “If the data holds up in the submission, you could start kids on their primary baseline months earlier than if you don’t do anything until the third-dose data comes in,” the source said.

Pfizer has already updated its trial data before showcasing the results in front of the federal health experts which included Dr. Anthony Fauci.

“There’s interest in seeing this move forward,” a Biden administration official stated. “To get to three, you have to get two shots first.”

It is quoted that the Covid-19 vaccine shots to be administered on this last remaining group of kids will have one-tenth of the strength of the adult will be safe for the kids and will not have an adverse effect on the immunity of young children.

The Biden administration believes that vaccinating shots are mandatory in order to keep the daycare centers and schools open amidst the ongoing pandemic and surging new variants such as the omicron variant. It will also keep the parents’ tension-free at their work as their children will be completely vaccinated and protected from the virus.